醫療保健 · Healthcare
開啟互動頁面（K 線、成交價圖）Open interactive page →
AMLX · Amylyx Pharmaceuticals, Inc.
內部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
Amylyx Pharmaceuticals, Inc.（AMLX）內部人交易：2026-07-01 至 2026-10-22，內部人公開市場買入 —、賣出 $4.3M；高管董事有效買入 —、有效賣出 —。最近申報 2026-10-07。
買入 Bought—
賣出 Sold$4.3M
有效買入 Effective bought—
有效賣出 Effective sold—
最近申報 Recent filings
| 交易日 | 內部人 | 類型 | 股數 | 價格 | 金額 | |
|---|---|---|---|---|---|---|
| 2026-10-05 | MILNE GEORGE M JR Director | 賣出 Sell | 30,000 | $27.70 | $831K | SEC |
| 2026-09-10 | Klee Justin B. Co-Chief Executive Officer, Director | 賣出 Sell | 30,464 | $32.18 | $980K | SEC |
| 2026-09-10 | Cohen Joshua B Co-Chief Executive Officer, Director | 賣出 Sell | 30,464 | $32.19 | $981K | SEC |
| 2026-09-10 | Mazzariello Gina Chief Legal Officer | 賣出 Sell | 9,536 | $32.46 | $310K | SEC |
| 2026-09-10 | FRATES JAMES M Chief Financial Officer | 賣出 Sell | 10,810 | $32.36 | $350K | SEC |
| 2026-09-10 | Bedrosian Camille L Chief Medical Officer | 賣出 Sell | 10,028 | $32.40 | $325K | SEC |
| 2026-07-09 | Mazzariello Gina Chief Legal Officer | 賣出 Sell | 30,000 | $17.96 | $539K | SEC |
「有效」= 高管或董事的公開市場主動買賣，排除 10b5-1 計劃、行權賣出、繳稅賣出、IPO/認購等。
擬出售 Form 144
| 預計出售日 | 申報人 | 股數 | 約金額 | |
|---|---|---|---|---|
| 2026-10-05 | MILNE GEORGE M JR Director | 100,000 | $2.8M | 10b5-1 |
| 2026-09-10 | Cohen Joshua B Officer, Director | 30,464 | $981K | |
| 2026-09-10 | Klee Justin B. Officer, Director | 30,464 | $980K | |
| 2026-09-10 | FRATES JAMES M Officer | 10,810 | $350K | |
| 2026-09-10 | Bedrosian Camille L Officer | 10,028 | $325K | |
| 2026-09-10 | Mazzariello Gina Officer | 9,536 | $310K | |
| 2026-07-09 | Mazzariello Gina Officer | 30,000 | $536K | 10b5-1 |
內部人 Insiders
MILNE GEORGE M JR、Klee Justin B.、Cohen Joshua B、Mazzariello Gina、FRATES JAMES M、Bedrosian Camille L